Research programme: antibacterials - Basilea Pharmaceutica

Drug Profile

Research programme: antibacterials - Basilea Pharmaceutica

Alternative Names: BAL 19764; BAL 29880; BAL0019764; BAL0029641; BAL0030205; BAL2057; BAL30376; HKI9924109

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Basilea Pharmaceutica
  • Class Macrolides; Monobactams
  • Mechanism of Action Beta lactamase inhibitors; Cell wall inhibitors; Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Acne; Gram-negative infections; Gram-positive infections; Rosacea

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Acne in Switzerland (Topical)
  • 04 Nov 2017 No recent reports of development identified for preclinical development in Gram-negative-infections in Germany (Parenteral)
  • 04 Nov 2017 No recent reports of development identified for preclinical development in Gram-negative-infections in Switzerland (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top